- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in Androgen Receptor Targeted Therapy for Prostate Cancer
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 229, Issue 3, Pages 271-276
Publisher
Wiley
Online
2013-08-22
DOI
10.1002/jcp.24456
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- In vitro model systems to study androgen receptor signaling in prostate cancer
- (2013) Natalie Sampson et al. ENDOCRINE-RELATED CANCER
- Advancing Precision Medicine for Prostate Cancer Through Genomics
- (2013) Sameek Roychowdhury et al. JOURNAL OF CLINICAL ONCOLOGY
- New Agonist- and Antagonist-Based Treatment Approaches for Advanced Prostate Cancer
- (2013) Y Xu et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Novel therapeutic approaches for the treatment of castration-resistant prostate cancer
- (2013) Isabel Heidegger et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Re: Effect of Abiraterone Acetate and Prednisone Compared with Placebo and Prednisone on Pain Control and Skeletal-Related Events in Patients with Metastatic Castration-Resistant Prostate Cancer: Exploratory Analysis of Data from the COU-AA-301 Randomised Trial
- (2013) Samir S. Taneja JOURNAL OF UROLOGY
- Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer
- (2013) Javier Guerrero et al. PROSTATE
- Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression
- (2013) Ayesha A. Shafi et al. STEROIDS
- Targeting the Adrenal Gland in Castration-Resistant Prostate Cancer: A Case for Orteronel, a Selective CYP-17 17,20-Lyase Inhibitor
- (2013) Hui Zhu et al. Current Oncology Reports
- Enzalutamide, a Second Generation Androgen Receptor Antagonist: Development and Clinical Applications in Prostate Cancer
- (2013) Manoj P. Menon et al. Current Oncology Reports
- Abiraterone and Novel Antiandrogens: Overcoming Castration Resistance in Prostate Cancer
- (2012) R. Ferraldeschi et al. Annual Review of Medicine
- Methoxychalcone inhibitors of androgen receptor translocation and function
- (2012) Yeong Sang Kim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
- (2012) Peter Grimm et al. BJU INTERNATIONAL
- Androgenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: a systematic review
- (2012) André D Sasse et al. BMC CANCER
- The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man
- (2012) Naomi L. Sharma et al. CANCER CELL
- ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
- (2012) N. J. Clegg et al. CANCER RESEARCH
- Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100
- (2012) J. Richards et al. CANCER RESEARCH
- Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
- (2012) R. Hu et al. CANCER RESEARCH
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Abiraterone in Prostate Cancer: A New Angle to an Old Problem
- (2012) M. N. Stein et al. CLINICAL CANCER RESEARCH
- Targeting the androgen receptor in the management of castrationresistant prostate cancer: rationale, progress, and future directions
- (2012) R. Leibowitz–Amit et al. Current Oncology
- Androgen Receptor Directed Therapies in Castration-Resistant Metastatic Prostate Cancer
- (2012) Won Kim et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- The evolution of antiandrogens: MDV3100 comes of age
- (2012) Lucy Dumas et al. Expert Review of Anticancer Therapy
- Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys
- (2012) Masuo Yamaoka et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats
- (2012) Takahito Hara et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Abiraterone and castration-resistant prostate cancer
- (2012) Talha Khan Burki LANCET ONCOLOGY
- Vav3 Enhances Androgen Receptor Splice Variant Activity and Is Critical for Castration-Resistant Prostate Cancer Growth and Survival
- (2012) Stephanie O. Peacock et al. MOLECULAR ENDOCRINOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Bone Remodeling by Isoflavone and 3,3′-Diindolylmethane in the Context of Prostate Cancer Bone Metastasis
- (2012) Yiwei Li et al. PLoS One
- The Impact of Point Mutations in the Human Androgen Receptor: Classification of Mutations on the Basis of Transcriptional Activity
- (2012) Colin W. Hay et al. PLoS One
- Mechanism of Androgen Receptor Antagonism by Bicalutamide in the Treatment of Prostate Cancer
- (2011) D. J. Osguthorpe et al. BIOCHEMISTRY
- Inactivation of AR/TMPRSS2-ERG/Wnt Signaling Networks Attenuates the Aggressive Behavior of Prostate Cancer Cells
- (2011) Y. Li et al. Cancer Prevention Research
- Targeting Continued Androgen Receptor Signaling in Prostate Cancer
- (2011) C. Massard et al. CLINICAL CANCER RESEARCH
- New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway
- (2011) G. Attard et al. CLINICAL CANCER RESEARCH
- Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
- (2011) Biswajyoti Sahu et al. EMBO JOURNAL
- A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease
- (2011) Vanessa C. Thompson et al. INTERNATIONAL JOURNAL OF CANCER
- Novel Therapies for Metastatic Castrate-Resistant Prostate Cancer
- (2011) F. Dayyani et al. JNCI-Journal of the National Cancer Institute
- Novel Therapeutic Strategies for Metastatic Prostate Cancer in the Post-Docetaxel Setting
- (2011) O. Sartor et al. ONCOLOGIST
- Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
- (2011) Bin Bao et al. PLoS One
- Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells
- (2011) J. T. De Leon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel targets for prostate cancer chemoprevention
- (2010) Fazlul H Sarkar et al. ENDOCRINE-RELATED CANCER
- Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
- (2010) Howard I Scher et al. LANCET
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
- (2010) P. A. Watson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A
- (2009) Andreas Desiniotis et al. INTERNATIONAL JOURNAL OF CANCER
- Inactivation of uPA and its receptor uPAR by 3,3′-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration
- (2009) Aamir Ahmad et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target
- (2009) Yu Chen et al. LANCET ONCOLOGY
- New Difluoro Knoevenagel Condensates of Curcumin, Their Schiff Bases and Copper Complexes as Proteasome Inhibitors and Apoptosis Inducers in Cancer Cells
- (2009) Subhash Padhye et al. PHARMACEUTICAL RESEARCH
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Castration-resistant prostate cancer: Targeting androgen metabolic pathways in recurrent disease
- (2009) Elahe A. Mostaghel et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
- (2008) S. M. Dehm et al. CANCER RESEARCH
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
- (2008) R. B. Montgomery et al. CANCER RESEARCH
- In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors
- (2008) R. Snoek et al. CLINICAL CANCER RESEARCH
- Molecular signaling pathways that regulate prostate gland development
- (2008) Gail S. Prins et al. DIFFERENTIATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started